Trial Details
Not recruitingBasic Information
| Clinical ID | c2324 |
|---|---|
| Identifier | NCT05299931 |
| Trial Title | An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (REScUE-OLE) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn Disease |
| Interventions | Drug: Ustekinumab |
Participant Information
| Sponsor | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW |
|---|---|
| City | - |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |